Over the last decade, the field of cell therapy has rapidly grown, and it holds enormous promise for treating many diseases. There are still factors like manufacturing maze, investment, logistics and regulatory challenges which prevents the cell and gene therapies to be widely used. We are once again putting together a unique platform to provide the exact solutions to these robust manufacturing and bioprocessing challenges, at our 3rd Annual MarketsandMarkets Cell & Gene Therapy Manufacturing Virtual Conference.
We have created a virtual engaging model that will be beneficial for speakers, attendees and sponsors/exhibitors, taking place on 28th - 29th October 2021.
Learn from the leading experts of the industry about strategies, technologies and innovations in the area of bioprocessing of cell-gene therapies.
From Therapeutics and Pharmaceuticals, Cell & Gene therapy-based companies:
Engineers/Scientists/Researchers/Project leaders in: Bioprocess development,
Process development, GMP/Manufacturing, Cellular Therapy, Gene Therapy, Quality Control, Cell Engineering, Regulatory affairs
From Universities and Research Institutes:
Scientists/Professors/Researchers/Project leaders in: Bioprocessing, Bioengineering, Biomaterials, Chemical Engineering, Material Sciences, Cell therapy, Gene therapy, Cell culture, Cell Engineering, GMP/Manufacturing